Medicure (STU:NGQ1) Short Interest


STU:NGQ1 Medicure Inc STU:NGQ1
62 GF Score
Price €0.63
GF Value €0.76
! 6 Warning Signs
View Full Analysis

What is Medicure Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:NGQ1 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicure Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Short Interest distribution charts can be found below:

* The bar in red indicates where Medicure's Short Interest falls into.


STU:NGQ1
62GF Score
Medicure Inc STU:NGQ1
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medicure (STU:NGQ1) Overvalued in 2026?

Based on GuruFocus' analysis, Medicure stock appears to be undervalued. The current stock price of €0.63 is trading 17.8% below its estimated GF Value™ of €0.76.

Key valuation signals for STU:NGQ1:

  • Short Interest:
  • GF Value™: €0.76 vs. price of €0.63 (17.8% below fair value)
  • GF Score™: 62/100 with 6 warning signs

No single metric tells the full story. See the STU:NGQ1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medicure Business Description

Other Exchanges MCUJF:USAMPH:Canada
Address 1250 Waverley Street, No. 2, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market and sales to the Retail Public of pharmaceutical products. The Company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and increasing its e-commerce and mail order pharmaceutical business. The Company operates under two segments: the marketing and distribution of commercial products and the operation of a retail and mail order pharmacy. It generates the majority of its revenue from the Retail and Mail Order Pharmacy segment.
62GF Score

Get the complete analysis for STU:NGQ1

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.63
Price
€0.76
GF Value